Pricing Log in Create free account

Creative Medical Technology Holdings, Inc. (CELZ) vs NeuroSense Therapeutics Ltd. (NRSN)

Creative Medical Technology Holdings, Inc. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. NeuroSense Therapeutics Ltd. is the larger, with a market value of $6.0M against $5.4M — 1.1× the size. Across the 7 metrics below, Creative Medical Technology Holdings, Inc. leads on 4 and NeuroSense Therapeutics Ltd. on 3.

Valuation

Metric CELZ NRSN Biotechnology median
P/E n/m n/m 8.50
P/S 161.13 n/m 9.71
P/B 0.32 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.98 n/m 0.64
EV/Sales (351.86) n/m 9.21
Earnings yield (279.73%) (406.90%) (33.15%)
Free cash flow yield (409.71%) (444.35%) (25.50%)

Profitability

Metric CELZ NRSN Biotechnology median
Gross margin 61.18% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) 0.00% (56.36%)
Return on assets (73.30%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ NRSN Biotechnology median
Revenue growth (TTM) (79.42%) — 6.02%
EPS growth (last fiscal year) 32.08% 18.52% 30.26%
Revenue growth, 5-year CAGR (48.43%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 0.28 4.72
Net debt to EBITDA 1.20 0.01 0.96

Dividend

Metric CELZ NRSN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CELZ NRSN Biotechnology median
Market cap 5.39m 6.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack